These guidelines have been prepared by member committees within the Brazilian Society of Rheumatology consisting of experienced researchers and clinicians who revised, analyzed and discussed the literature in order to provide the best evidence-based recommendations for a given diagnosis or treatment in the field of Rheumatology. None of these guidelines have been sponsored by pharmaceutical companies. All of them have been peer-reviewed by independent referees.
Recommendations of the Brazilian Society of Rheumatology for the use of JAK inhibitors in the management of rheumatoid arthritis
Rheumatoid arthritis (RA) is a chronic and autoimmune systemic inflammatory disease that can cause irreversible joint deformities, with increased morbidity and mortality and a significant impact on the quality...